MedTrace Logo

Pet Ownership and Glucose Control in Early Adolescents With Type 1 Diabetes

NCT03761251 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2019-10-02

No results posted yet for this study

Summary

This study evaluates the short-term effects of incorporating the structured care of a pet fish into a diabetes self-care routine on glucose control in early adolescents with type 1 diabetes.

Conditions

  • Diabetes Mellitus, Type 1
  • Adolescent Behavior

Interventions

BEHAVIORAL

Pet Fish

Participants will be provided a fish tank with supplies to care for the fish and access to a fish (Betta splendens) from a local pet store. All participants will receive specific instructions for coupling the fish care and diabetes care: 1. feed fish one pellet in the morning after waking; check and record BG reading at that time 2. feed fish one pellet in the evening before dinner; check and record BG reading at that time 3. feed fish one pellet at night before bedtime; check and record BG reading at that time 4. every week clean the tank alternating with test the water quality in partnership with caregiver; review blood glucose readings with caregiver with each weekly fish care activity and problem solve any issues related to the blood glucose pattern. Each child will also receive two books intended to supplement and enrich their pet fish experience.

Sponsors & Collaborators

  • University of Texas Southwestern Medical Center

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
10 Years
Max Age
13 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-31
Primary Completion
2019-07-09
Completion
2019-09-25

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03761251 on ClinicalTrials.gov